Arax Advisory Partners’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
TA
OIA
TWM
FGA
FHA
Arax Advisory Partners's BTAL Position: Q1 2024 in Review
Arax Advisory Partners sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2024, closing a stake of 12 shares — an estimated $204 sold.
Arax Advisory Partners first reported a position in BTAL in Q4 2023 and held it in 1 quarter. The position peaked at $204 in Q4 2023. 61 funds tracked by Wall St. Rank hold BTAL as of Q1 2024.
- Arax Advisory Partners reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2024 after selling out during the quarter.
- Arax Advisory Partners sold 12 AGF US Market Neutral Anti-Beta Fund shares in Q1 2024, an estimated $204.
- Arax Advisory Partners first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and held it in 1 quarter.
- Arax Advisory Partners's AGF US Market Neutral Anti-Beta Fund position peaked at $204 in Q4 2023.
- 61 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2024.
Based on Arax Advisory Partners's 13F filing for Q1 2024, filed 14 May 2024.